Determination of saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography and the analytical error function

Journal of Pharmaceutical and Biomedical Analysis

Volumn 36, Issue 4, 2004, Pages 835-840

  Albert, Verónica ^a   Modamio, Pilar ^a   Lastra, Cecilia F ^a   Mariño, Eduardo L ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Analytical error function; Human plasma; Reversed phase high performance liquid chromatography; Ritonavir; Saquinavir

Indexed keywords

ACETONITRILE; PROTEINASE INHIBITOR; RITONAVIR; SAQUINAVIR;

ACCURACY; ANALYTIC METHOD; ANALYTICAL ERROR; ARTICLE; BLOOD ANALYSIS; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; DEVICE; DRUG DETERMINATION; DRUG RETENTION; DRUG STABILITY; DRUG STORAGE; HUMAN; LIQUID LIQUID EXTRACTION; PRIORITY JOURNAL; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; HUMANS; RESEARCH DESIGN; RITONAVIR; SAQUINAVIR;

EID: 7944230755     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2004.08.013     Document Type: Article

References (24)

1. T.N. Kakuda, K.A. Struble, and S.C. Piscitelli Am. J. Health-Syst. Pharm. 55 1998 233 254
2. R.M.W. Hoetelmans, M. Van Essenberg, M. Profijt, P.L. Meenhorst, J.W. Mulder, and J.H. Beijnen J. Chromatogr. B 705 1998 119 126
3. H.R. Ha, F. Follath, Y. Bloemhard, and S. Krähenbühl J. Chromatogr. B 694 1997 427 433
4. K.C. Marsh, E. Eiden, and E. McDonald J. Chromatogr. B 704 1997 307 313
5. M.A. Campanero, M. Escolar, M.A. Arangoa, B. Sádaba, and J.R. Azanza Biomed. Chromatogr. 16 2002 7 12
6. R.M.W. Hoetelmans, M. Van Essenberg, P.L. Meenhorst, J.W. Mulder, and J.H. Beijnen J. Chromatogr. B 698 1997 235 241
7. E.L. Mariño, J.M. Jansat, M.A. March, and C.F. Lastra Int. J. Clin. Pharmacol. Ther. 34 1996 546 549
8. R. Causon J. Chromatogr. B 689 1997 175 180
9. C. Hartmann, J. Smeyers-Verbeke, D.L. Massart, and R.D. McDowall J. Pharm. Biomed. Anal. 17 1998 193 218
10. U.S. Department of Health and Human Services, Food and Drug Administration (FDA), Center for Drug Evaluation and Research (CDER), Center for Veterinary Medicine (CVM), Guidance for Industry, Bioanalytical Method Validation, 2001. http://www.fda.gov/cder/guidance/4252fnl.pdf.
11. S. Furlanetto, S. Orlandini, P. Mura, M. Sergent, and S. Pinzauti Anal. Bioanal. Chem. 377 2003 937 944
12. C.A. James, M. Breda, and E. Frigerio J. Pharm. Biomed. Anal. 35 2004 887 893
13. P. Modamio, C.F. Lastra, and E.L. Mariño J. Pharm. Biomed. Anal. 14 1996 401 408
14. P. Modamio, C.F. Lastra, and E.L. Mariño J. Pharm. Biomed. Anal. 17 1998 507 513
15. F. Liard, E. Ghiro, W. Paris, and C. Yoakim J. Pharm. Biomed. Anal. 14 1995 151 154
16. P.W.H. Hugen, C.P.W.G.M. Verweij-van Wissen, D.M. Burger, E.W. Wuis, P.P. Koopmans, and Y.A. Hekster J. Chromatogr. B 727 1999 139 149
17. H. Yamada, H. Kotaki, T. Nakamura, and A. Iwamoto J. Chromatogr. B 755 2001 85 89
18. T.P. Moyer, Z. Temesgen, R. Ener, L. Estes, L. Charlson, L. Oliver, and A. Wright Clin. Chem. 45 1999 1465 1476
19. H.R. Wiltshire, B.G. Wiltshire, A.F. Clarke, E. Worth, K.J. Prior, and J.F. Tjia Anal. Biochem. 281 2000 105 114
20. D.M. Burger, M. Graaff, E.W. Wuis, P.P. Koopmans, and Y.A. Hekster J. Chromatogr. B 703 1997 235 241
21. A.J. Braza, P. Modamio, C.F. Lastra, and E.L. Mariño Biomed. Chromatogr. 16 2002 517 522
22. R.W. Jelliffe, A. Schumitzky, D. Bayard, M. Milman, M. Van Guilder, X. Wang, F. Jiang, X. Barbaut, and P. Maire Clin. Pharmacokinet. 34 1998 57 77
23. R.W. Jelliffe Int. J. Clin. Pharmacol. Ther. 42 2004 183 184
24. I.B. Bondareva, R.W. Jelliffe, A.V. Sokolov, and I.F. Tischenkova J. Clin. Pharm. Ther. 29 2004 105 120